Hook-shaped dose-response curves for trappable and non-trappable blockers simulated using our modified version of the O’Hara-Rudy model of the undiseased human heart as a function... by Hongbin Wan (1904146)

Predicted distance (km) needed to achieve a correlation coefficient of at least r =  0.50 using the median-based linear regression models. by Claire Stevens (11127729)

<i>Sdc1</i>^-/- mice have normal leukocyte recruitment to the parietal peritoneum microcirculation. by Paulina M. Kowalewska (625078)

“…<p>Wild-type and <i>Sdc1</i>^-/- mice were injected IP with 50<i> µ</i>L of saline, <i>S. aureus</i> LTA (125<i> µ</i>g), <i>E. coli</i> LPS (125<i> µ</i>g) or TNF<i>α</i> (500 ng). …”

Dry matter intake (over the experiment), peformance, feed efficiency and faecal score of Holstein calves fed different additives in the starter feed (n = 50). by Luisa F. L. Salazar (6664121)

Experimental protocol consisting of four blocks (Unsupported Walking (UW), Body Weight Support (BWS), BWS + Mediolateral (ML) Forces, BWS + Anteroposterior (AP) Forces), separated... by Sanne Ettema (18786312)

Step parameters for Unsupported Walking (UW), Body Weight Support (BWS, upper panel), Mediolateral Forces (ML, middle panel) and Anteroposterior Forces (AP, lower panel). by Sanne Ettema (18786312)

Syndecan-1 expression in the abdominal wall and plasma does not change after LTA injection. by Paulina M. Kowalewska (625078)

Five main steps of MATSim. by Jingfa Ma (20396406)

Characteristics of the study population. by Sanne Ettema (18786312)

If a bird calls, will we detect it? Factors that can influence the detectability of calls on automated recording units in field conditions by Abby Thomas (9288104)

Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes by Yun Wu (150224)

Subjects:

Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes by Yun Wu (150224)

Subjects:

Flowchart of data preprocessing steps. by Ehsan Yaghmaei (16985784)

Imaging setup and step parameters. by César S. Mendes (650719)

“…(D) All non-upright animals display increased step length. (E) Swing duration is increased only in ascending and descending animals while inverted animals show a small decrease. …”

The dynamics of sickle RBCs interacting with a macrophage under a blood flow with step-wise changes. by Guansheng Li (10170467)

“…<p>A Sequential snapshots of RBCs adhering to macrophages under velocities that are decreased step-wise. …”

Image_1_Experimental Treatment of Hazardous Ash Waste by Microbial Consortium Aspergillus niger and Chlorella sp.: Decrease of the Ni Content and Identification of Adsorption Sites... by Alexandra Šimonovičová (11011494)

Antibodies used for flow cytometry experiments. by Joseph Rabin (7399436)

“…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …”

Subject flow diagram. by Joseph Rabin (7399436)

“…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …”

Essential oil-incorporated carbon nanotubes filters for bacterial removal and inactivation - Fig 4 by Xiuli Dong (658906)

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”